Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Pradaxa Bleeding Reports Provide ‘Distorted Estimate’ of Risk: FDA Staff March 18, 2013 Irvin Jackson Add Your Comments Federal health officials are suggesting that the recent surge in adverse event reports involving bleeding problems with Pradaxa, an anticoagulant that has been linked to thousands of cases involving uncontrollable hemorrhages, may be exaggerated due to a greater likelihood for doctors and patients to report issues with the relatively new medication. Pradaxa (dabigatran) was introduced by drug maker Boehringer Ingelheim in October 2010, as a superior alternative to warfarin, or Coumadin, which has been the go-to anticoagulant treatment for decades. The medication has been promoted as easier to use than warfarin, because it requires less monitoring. However, the FDA has seen the number of adverse event reports associated with Pradaxa eclipse warfarin and most other approved medications, with doctors reporting that patients were experiencing severe and often fatal bleeding after taking the medication. Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Pradaxa Internal Bleeding Lawsuit Side effects of Pradaxa may increase risk of severe bleeding and death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION During the first full year the drug was on the market in the United States, the Institute for Safe Medication Practices (ISMP) found that adverse event reports involving problems with Pradaxa surpassed all other medications regularly monitored by the group. FDA received at least 3,781 reports involving serious injuries associated with the use of Pradaxa during 2011, including 2,367 reports of hemorrhage and 542 patient deaths. “Stimulated Reporting” May Have Led to Pradaxa Adverse Event Reports In an editorial published last week in the New England Journal of Medicine, researchers from the FDA addressed why the agency may have received so many reports involving Pradaxa, while studies have suggested that Pradaxa bleeding events occur at a similar rate as those caused by warfarin. The editorial suggests that the increased reports were likely seen because Pradaxa is newer and bleeding events were widely reported in the media. “We believe that the large number of reported cases of bleeding associated with dabigatran provides a salient example of stimulated reporting,” the researchers concluded. “In this case, such reporting provided a distorted estimate of the comparative bleeding rates associated with dabigatran and warfarin in clinical practice.” However, some experts and doctors have pointed out that while the bleeding rates may be similar, problems with the warnings provided with Pradaxa and the lack of a reversal agent may have caused the higher number of bleeding events in use outside of clinical trials. Warfarin has an antidote, known as a reversal agent, to stop bleeding events that may occur during therapy. However, there is no such quick-fix available for Pradaxa, and concerns have been raised within the medical community about an inability to stop hemorrhaging with Pradaxa. The editorial does not address the lack of a Pradaxa reversal agent. According to another report issued by the Institute for Safe Medication Practices (ISMP) earlier this year, Pradaxa adverse event reports submitted during the second quarter of 2012 continued to be alarmingly high, with Pradaxa generating 956 complaints (including 178 deaths), compared to 214 complaints involving warfarin (with only 14 deaths). The ISMP report suggested that bleeding problems with Pradaxa may be five times more likely to result in death for a patient when compared to those associated with the use of warfarin, highlighting the impact of the lack of a reversal agent. While the ISMP does acknowledge a possible effect of the media reporting of Pradaxa bleeding events on adverse events submitted to the FDA, the report also noted that a New Zealand study found that prescribing errors, kidney problems among users and an older patient population is also play a factor in the large number of Pradaxa deaths. Pradaxa Lawsuits Allege Failure to Warn About Risk, Lack of Reversal Agent Boehringer Ingelheim currently faces several hundred Pradaxa lawsuits filed in courts throughout the United States on behalf of former users of the anticoagulant who have experienced severe or fatal bleeding problems. The complaints allege that the drug maker failed to adequately warn about the risk of health problems, the importance of screening potential users of the medication and the lack of a reversal agent to stop bleeding problems that may develop. In the federal court system, the Pradaxa litigation is centralized before U.S. District Judge David R. Herndon as part of an MDL, or multidistrict litigation. A case management plan has been established where a handful of cases are being prepared for early trial dates, which are expected to go to trial in August 2014. The parties have also been ordered to meet every month starting in August 2013, to discuss potential Pradaxa settlement agreements. Judge Herndon has indicated that the aggressive schedule for the litigation was established in an attempt to reach an “expeditious resolution to the factual allegations made”, which will benefit both plaintiffs, the drug maker and the medical community. Tags: Bleeding, Blood Thinner, Blood Thinners, Boehringer Ingelheim, Coumadin, Pradaxa, Warfarin More Pradaxa Lawsuit Stories Jury Awards $540K in Pradaxa Trial Against Boehringer Ingelheim May 21, 2019 Paragard IUD Lawsuit Dismissed on Summary Judgment February 25, 2019 Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025) 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Boehringer Ingelheim Ordered to Pay $1.25M For Failure to Warn About Pradaxa Bleeding Risks October 25, 2018
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: today) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)